Amgen Profit Rises 27% on Higher Sales of Key Drugs

Amgen Inc. said its fourth-quarter earnings rose 27%, as sales growth was again driven by key drugs such as cancer therapy drug Kyprolis and osteoporosis treatment Prolia.



from WSJ.com: US Business http://ift.tt/1D6uphL

via IFTTT